Immediate Impact
21 standout
Citing Papers
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Bladder cancer
2023 Standout
Works of Thomas McGowan being referenced
PD66-06 PROSPECTIVE EVALUATION OF CYSTOSCOPY AND BLADDER MAPPING REVEALS NEARLY A 30% MISS RATE FOR ≥PT2 PATHOLOGY
2019
Standardized Synoptic Cancer Pathology Reports — So What and Who Cares?: A Population-Based Satisfaction Survey of 970 Pathologists, Surgeons, and Oncologists
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas McGowan | 40 | 119 | 146 | 95 | 13 | 319 | |
| Judith A. Wolfman | 39 | 126 | 164 | 85 | 13 | 325 | |
| Constantino Herranz | 75 | 96 | 137 | 129 | 9 | 309 | |
| D Ryan | 30 | 41 | 153 | 80 | 13 | 282 | |
| Jennifer M. Racz | 30 | 70 | 96 | 115 | 28 | 358 | |
| S Patriarca | 18 | 67 | 152 | 35 | 22 | 282 | |
| Anne Cowppli‐Bony | 11 | 104 | 157 | 71 | 17 | 340 | |
| F Reale | 78 | 75 | 38 | 71 | 18 | 307 | |
| Lonzetta Neal | 24 | 22 | 93 | 93 | 16 | 299 | |
| Cecilia Wattsgård | 15 | 38 | 126 | 70 | 9 | 360 | |
| Sun Yang Chung | 60 | 35 | 91 | 112 | 16 | 265 |
All Works
Loading papers...